Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,710 | -26,630 | -42,920 | -48,050 | -41,680 |
| Depreciation Amortization | 7,210 | 3,570 | 3,060 | 2,340 | 1,580 |
| Income taxes - deferred | N/A | N/A | -11,320 | N/A | N/A |
| Accounts receivable | N/A | N/A | -511 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 800 | N/A | N/A |
| Other Working Capital | -1,840 | 0 | -1,690 | 3,780 | -3,220 |
| Other Operating Activity | 34,540 | 20,670 | 31,911 | 28,280 | 29,860 |
| Operating Cash Flow | $-7,800 | $-2,390 | $-20,670 | $-13,650 | $-13,460 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 6,067 | N/A | N/A |
| PPE Investments | -710 | -390 | -20 | -750 | -500 |
| Other Investing Activity | -23,420 | -27,400 | -7 | 4,960 | 5,010 |
| Investing Cash Flow | $-24,130 | $-27,790 | $6,040 | $4,210 | $4,510 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 19,333 | N/A | N/A |
| Debt Repayment | N/A | N/A | -552 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 400 | N/A | N/A |
| Other Financing Activity | 80,910 | 80,070 | -911 | 14,380 | 14,560 |
| Financing Cash Flow | $80,910 | $80,070 | $18,270 | $14,380 | $14,560 |
| Exchange Rate Effect | -1,510 | -1,010 | 250 | 110 | -20 |
| Beginning Cash Position | 6,630 | 6,630 | 2,740 | 2,740 | 2,740 |
| End Cash Position | 54,100 | 55,500 | 6,630 | 7,800 | 8,330 |
| Net Cash Flow | $47,460 | $48,870 | $3,890 | $5,060 | $5,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,800 | -2,390 | -20,670 | -13,650 | -13,460 |
| Capital Expenditure | N/A | N/A | -1,029 | N/A | N/A |
| Free Cash Flow | -7,800 | -2,390 | -21,699 | -13,650 | -13,460 |